211 related articles for article (PubMed ID: 29860247)
1. Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival.
Tas F; Erturk K
Pathobiology; 2018; 85(4):227-231. PubMed ID: 29860247
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
[TBL] [Abstract][Full Text] [Related]
3. Plantar melanoma is associated with certain poor prognostic histopathological factors, but not correlated with nodal involvement, recurrence, and worse survival.
Tas F; Erturk K
Clin Transl Oncol; 2018 May; 20(5):607-612. PubMed ID: 28948477
[TBL] [Abstract][Full Text] [Related]
4. Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype.
Lino-Silva LS; Domínguez-Rodríguez JA; Aguilar-Romero JM; Martínez-Said H; Salcedo-Hernández RA; García-Pérez L; Herrera-Gómez Á; Cuellar-Hubbe M
Ann Surg Oncol; 2016 Dec; 23(13):4189-4194. PubMed ID: 27401447
[TBL] [Abstract][Full Text] [Related]
5. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
Bradford PT; Goldstein AM; McMaster ML; Tucker MA
Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
[TBL] [Abstract][Full Text] [Related]
6. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients.
Teramoto Y; Keim U; Gesierich A; Schuler G; Fiedler E; Tüting T; Ulrich C; Wollina U; Hassel JC; Gutzmer R; Goerdt S; Zouboulis C; Leiter U; Eigentler TK; Garbe C
Br J Dermatol; 2018 Feb; 178(2):443-451. PubMed ID: 28707317
[TBL] [Abstract][Full Text] [Related]
7. [Local recurrence and survival in acral lentiginous melanoma comparing 3D histology and conventional histology].
Schulz C; Häfner HM; Breuninger H; Leiter U
J Dtsch Dermatol Ges; 2014 Oct; 12(10):881-90. PubMed ID: 25262892
[TBL] [Abstract][Full Text] [Related]
8. TERT gene amplification is associated with poor outcome in acral lentiginous melanoma.
Diaz A; Puig-Butillé JA; Muñoz C; Costa D; Díez A; Garcia-Herrera A; Carrera C; Badenas C; Solé F; Malvehy J; Puig S; Alos L
J Am Acad Dermatol; 2014 Oct; 71(4):839-41. PubMed ID: 25219713
[No Abstract] [Full Text] [Related]
9. Clinicopathological study of acral melanoma in situ in 44 Japanese patients.
Kato T; Kumasaka N; Suetake T; Tabata N; Tagami H
Dermatology; 1996; 193(3):192-7. PubMed ID: 8944339
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma in Taiwan: a prognostic study of 181 cases.
Chang JW; Yeh KY; Wang CH; Yang TS; Chiang HF; Wei FC; Kuo TT; Yang CH
Melanoma Res; 2004 Dec; 14(6):537-41. PubMed ID: 15577327
[TBL] [Abstract][Full Text] [Related]
11. The "spaghetti technique": an alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma).
Gaudy-Marqueste C; Perchenet AS; Taséi AM; Madjlessi N; Magalon G; Richard MA; Grob JJ
J Am Acad Dermatol; 2011 Jan; 64(1):113-8. PubMed ID: 21167406
[TBL] [Abstract][Full Text] [Related]
12. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
[TBL] [Abstract][Full Text] [Related]
13. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
14. Letter: Acral-lentiginous melanoma: Report of 15 cases.
Manganoni AM; Facchetti F; Gavazzoni F; Farisoglio C; Manca G; Sereni E; Marocolo D; Calzavara-Pinton PG
Dermatol Online J; 2011 Jan; 17(1):15. PubMed ID: 21272506
[No Abstract] [Full Text] [Related]
15. Treatments and associated outcomes of acral lentiginous melanoma: A review.
Lobl MB; Santos C; Clarey D; Higgins S; Silva-Lopez E; Sutton A; Wysong A
J Am Acad Dermatol; 2020 Jul; 83(1):230-234. PubMed ID: 31738961
[No Abstract] [Full Text] [Related]
16. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?
Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
J Am Acad Dermatol; 2015 Jan; 72(1):71-7. PubMed ID: 25455840
[TBL] [Abstract][Full Text] [Related]
17. Melanoma: clinical, evolutive and histopathological characteristics of a series of 136 cases.
Ocanha-Xavier JP; Xavier-Junior JCC; Marques MEA
An Bras Dermatol; 2018 Jun; 93(3):373-376. PubMed ID: 29924223
[TBL] [Abstract][Full Text] [Related]
18. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
[TBL] [Abstract][Full Text] [Related]
19. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
